Latest Market News

Telstra Group Limited has confirmed a fully franked ordinary dividend of 9.5 cents per share for the first half of FY25, alongside an updated Dividend Reinvestment Plan price reflecting recent trading activity.

SenSen Networks has secured $2 million in new contracts across Singapore, the USA, and Australia, reinforcing its position as a leader in Live Awareness AI solutions. The company also strengthened its balance sheet with $1.5 million cash received from a recent Montreal project.

Metal Powder Works Limited has completed a A$15 million institutional placement, strengthening its balance sheet to scale production and expand its market presence.

Samuel Terry Asset Management has launched an off-market takeover offer for all Eildon Capital Group stapled securities at A$0.80 per security, representing a notable premium over recent trading prices. The move aims to consolidate ownership and potentially delist Eildon Capital from the ASX.

Marimaca Copper has successfully raised A$80 million through a strongly supported placement, positioning the company to advance exploration and development at its flagship Chilean copper projects.

Astral Resources has reported robust gold intercepts from its recent drilling at the Spargoville Gold Project, highlighting potential to expand existing resources beneath the 8500N palaeochannel deposit. Concurrent exploration at Mandilla and lithium targets at KOMIR JV further underpin the company’s multi-asset growth strategy.

Olympio Metals reveals extensive gold mineralisation at its Bousquet Project in Quebec, highlighting promising high-grade drill results and new structural targets that suggest a potential multi-million ounce deposit.

4DMedical has secured multi-year agreements to deploy its advanced lung imaging technology across Brazil and Australia, supporting national lung cancer screening programs and enhancing lung health diagnostics.

Proteomics International has unveiled new clinical data confirming its PromarkerEso blood test can accurately detect early stages of esophageal adenocarcinoma, potentially transforming screening for a cancer with poor prognosis.

Hazer Group and First Graphene have signed a non-binding MOU to explore innovative applications for Hazer’s proprietary graphite, aiming to capitalize on rising global demand amid supply constraints.

Pathkey.AI’s TrialKey platform has demonstrated a 73% alignment with actual biotech trial outcomes, showing an average hypothetical share price gain of 76%, underscoring AI’s growing role in clinical trial prediction and biotech investing.

Southern Cross Gold Consolidated Ltd reports exceptional high-grade gold and antimony drill results from its Sunday Creek project in Victoria, revealing significant mineralization extensions both laterally and at depth.